Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Cyclohexanol | competitive | Equus caballus | |
propan-2-ol | competitive | Equus caballus |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.3 | - |
acycloNAD+ | substrate butan-1-ol, pH 8.0, 25°C | Equus caballus | |
0.33 | - |
acycloNAD+ | substrate hexan-1-ol, pH 8.0, 25°C | Equus caballus | |
0.33 | - |
acycloNAD+ | substrate propan-1-ol, pH 8.0, 25°C | Equus caballus | |
0.36 | - |
acycloNAD+ | substrate ethanol, pH 8.0, 25°C | Equus caballus | |
0.61 | - |
acycloNAD+ | substrate benzyl alcohol, pH 8.0, 25°C | Equus caballus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Equus caballus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
commercial preparation | - |
Equus caballus | - |
liver | - |
Equus caballus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
benzyl alcohol + acycloNAD+ | acycloNAD+ i.e. NAD+-analogue, where the nicotinamide ribosyl moiety has been replaced by the nicotinamide (2-hydroxyethoxy)methyl moiety | Equus caballus | benzaldehyde + acycloNADH + H+ | - |
? | |
butan-1-ol + acycloNAD+ | acycloNAD+ i.e. NAD+-analogue, where the nicotinamide ribosyl moiety has been replaced by the nicotinamide (2-hydroxyethoxy)methyl moiety | Equus caballus | butanal + acycloNADH + H+ | - |
? | |
ethanol + acycloNAD+ | acycloNAD+ i.e. NAD+-analogue, where the nicotinamide ribosyl moietyhas been replaced by the nicotinamide (2-hydroxyethoxy)methyl moiety | Equus caballus | acetaldehyde + acycloNADH + H+ | - |
? | |
hexan-1-ol + acycloNAD+ | acycloNAD+ i.e. NAD+-analogue, where the nicotinamide ribosyl moiety has been replaced by the nicotinamide (2-hydroxyethoxy)methyl moiety | Equus caballus | hexanal + acycloNADH + H+ | - |
? | |
additional information | acycloNAD+ i.e. NAD+-analogue, where the nicotinamide ribosyl moiety has been replaced by the nicotinamide (2-hydroxyethoxy)methyl moiety. There is no detectable reduction of acycloNAD+ by secondary alcohols although these alcohols serve as competitive inhibitors. AcycloNAD+ converts horse liver ADH from a broad spectrum alcohol dehydrogenase, capable of utilizing either primary or secondary alcohols, into an exclusively primary alcohol dehydrogenase | Equus caballus | ? | - |
? | |
propan-1-ol + acycloNAD+ | acycloNAD+ i.e. NAD+-analogue, where the nicotinamide ribosyl moiety has been replaced by the nicotinamide (2-hydroxyethoxy)methyl moiety | Equus caballus | propanal + acycloNADH + H+ | - |
? |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
acycloNAD+ | NAD+-analogue, where the nicotinamide ribosyl moiety has been replaced by the nicotinamide (2-hydroxyethoxy)methyl moiety. The chemical properties are comparable to those of beta-NAD+ with a redox potential of -324 mV and a 341 nm lambdamax for the reduced form. The stereochemistry of the hydride transfer in the oxidation of n-butanol is identical to that for the reaction with beta-NAD+. There is no detectable reduction of acycloNAD+ by secondary alcohols although these alcohols serve as competitive inhibitors. AcycloNAD+ converts horse liver ADH from a broad spectrum alcohol dehydrogenase, capable of utilizing either primary or secondary alcohols, into an exclusively primary alcohol dehydrogenase | Equus caballus |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
9.7 | - |
Cyclohexanol | pH 8.0, 25°C | Equus caballus | |
96 | - |
propan-2-ol | pH 8.0, 25°C | Equus caballus |